samedan logo

home > news > detailed info

Nemera launches UniSpray, its unidose system primarily for systemic-acting drug administration


Nemera has a proven track record in developing and manufacturing complex Ear Nose and Throat solutions. In line with clear growing market interest in unidose system coupled with promising advantages that nasal route could offer, Nemera is thrilled to extend its portfolio by launching its unidose system, UniSpray, for systemic-acting drug administration to face emergency and crisis.

Other than treating conditions locally, nasal delivery is an attractive option to also administer systemic therapies which may vary from benign to serious health conditions. What’s more, is that the nasal route is not invasive and does not require healthcare professionals’ intervention where patients can selfadminister their remedy with a rapid onset.

UniSpray is a ready-to-use primeless device with single-metered liquid dose delivery. It offers one-handed activation with 360° functionality to face emergency and crisis. Thanks to its ergonomic design, it is intuitive and easy-to-use.

UniSpray is a unidose system concept under development, designed to be robust and compatible with existing marketed primary containers. Through usability analysis and Freedom to Operate assessment, we assure reliability and regulatory compliance of our unidose concept.

Bernhard Rohn, VP Strategy and Marketing, commented: "Nemera has a longstanding experience in the nasal delivery route, focusing until now on multidose pumps. Adding UniSpray to our product range provides additional options for our customers and patients, answering the needs of the single-metered dose spray combination products"

Raphaële Audibert, Global Category Manager – ENT, added: “This is a great milestone for us. The increasing patient preference for nasal drug delivery as a result of easy administration and better efficacy as well as growing adoption of selfadministration practices are some of the key factors driving the growth of the nasal market.”

Come discover UniSpray at CPhI Worldwide in Milan, from 9th to 11th November, at booth 6J42. UniSpray at a glance:

  • Intuitive and robust device with ergonomic finger rest
  • Broad labeling surface
  • Safe and secured with no risk of accidental activation
  • Accelerates time-to-market thanks to possible adaptations to conventional filling lines
  • Equivalent utilization and performance as originators thanks to our in-vitro bioequivalence capability
  • Ready-to-use, primeless device, 360° functionality
  • Compatible with existing primary drug container
  • Single dose liquid delivery device with one accurate 100µL dose
  • Compliant to regulatory exigence
  • Customization possibilities
  • For new and repurposed drug, as well as generics
phone +33 4 74 94 06 54
email 20 avenue de la Gare, 38290 – La Verpilličre, France
Print this page
Send to a friend
News and Press Releases

Essentra Packaging underlines quality and service with high-performance paper sack range

Essentra Packaging, Bangor (NI), producers of multiwall paper sacks, has shared its perspective on the soaring demand for paper sack packaging, the forces it believes are driving this growth, and how its paper sack range is adding value for brand owners.
More info >>

White Papers

R&D to Product: How to Reduce Costly Scale-Up Problems

Natoli Engineering Company, Inc.

When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
More info >>

Industry Events

Connect in Pharma

14-15 September 2022, Plaexpo, Geneva, Switzerland

The new event driving innovation for pharma and biopharma businesses, Connect in Pharma will unite key players in Pharmaceutical and Biopharmaceutical packaging and production in Geneva on 14 – 15 September 2022.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement